{
    "title": "U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 mln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12295393/U-S-watchdog-lifts-price-estimate-Bluebird-Vertex-CRISPR-gene-therapies-2-1-mln.html",
    "date": "2023-07-13",
    "keywords": [
        "price",
        "gene",
        "year",
        "rind",
        "bhanvi",
        "satija",
        "pricing",
        "estimate",
        "bluebird",
        "sickle",
        "cell",
        "april",
        "icer",
        "blood",
        "pain",
        "patient",
        "treatment",
        "report",
        "hemophilia",
        "july",
        "drug",
        "watchdog",
        "pharmaceuticalscrispr",
        "bio",
        "mln",
        "cost",
        "effectiveness",
        "institute",
        "review",
        "disease",
        "shortage",
        "circulation",
        "assumption",
        "officer",
        "worth",
        "range",
        "manufacturer",
        "list",
        "hemgenix",
        "b",
        "biomarin",
        "impact",
        "issue",
        "amount",
        "nervousness",
        "reporting",
        "bengaluru"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}